Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mahajan

Showing results (291-300 of 313) with videos related to

Pageof 32
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 18, 2022
Acetylated HOXB13 Regulated Super Enhancer Genes Define Therapeutic Vulnerabilities of Castration-Resistant Prostate CancerDuy T Nguyen, Wei Yang, Arun Renganathan, et al.
Oncotarget|December 1, 2016
The non-receptor tyrosine kinase TNK2/ACK1 is a novel therapeutic target in triple negative breast cancerXinyan Wu, Muhammad Saddiq Zahari, Santosh Renuse, et al.
Nature Communications|September 27, 2023
Author Correction: Histone H2A Lys130 acetylation epigenetically regulates androgen production in prostate cancerThanh Nguyen, Dhivya Sridaran, Surbhi Chouhan, et al.
Anesthesiology|January 13, 2017
Retesting the Hypothesis of a Clinical Randomized Controlled Trial in a Simulation Environment to Validate Anesthesia Simulation in Error Research (the VASER Study)Alan F Merry, Jacqueline A Hannam, Craig S Webster, et al.
Nature Communications|June 9, 2023
Histone H2A Lys130 acetylation epigenetically regulates androgen production in prostate cancerThanh Nguyen, Dhivya Sridaran, Surbhi Chouhan, et al.
Oncogene|June 17, 2023
Epigenetic reprogramming of cell cycle genes by ACK1 promotes breast cancer resistance to CDK4/6 inhibitorMithila Sawant, Audrey Wilson, Dhivya Sridaran, et al.
Global Advances in Integrative Medicine and Health|May 25, 2026
Implementing an Integrative Medicine Group Visit Facilitator Training Program to Improve Chronic Pain Management in the Safety-NetEmiley Chang, Ruth Sie, Maria G Mechure, et al.
Cancers|January 11, 2024
Symptomatic Benign Prostatic Hyperplasia with Suppressed Epigenetic Regulator HOXB13 Shows a Lower Incidence of Prostate Cancer DevelopmentNimrod S Barashi, Tiandao Li, Duminduni H Angappulige, et al.
Oncogenesis|May 23, 2017
AKT is indispensable for coordinating Par-4/JNK cross talk in p21 downmodulation during ER stressR U Rasool, D Nayak, S Chakraborty, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 27, 2024
Prostate-Specific Membrane Antigen-Targeted Imaging and Its Correlation with HOXB13 ExpressionDuminduni Hewa Angappulige, Nimrod S Barashi, Nicholas Pickersgill, et al.
Pageof 32

Showing results (291-300 of 313) with videos related to

Sort By:
Pageof 32
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 18, 2022
Acetylated HOXB13 Regulated Super Enhancer Genes Define Therapeutic Vulnerabilities of Castration-Resistant Prostate CancerDuy T Nguyen, Wei Yang, Arun Renganathan, et al.
Oncotarget|December 1, 2016
The non-receptor tyrosine kinase TNK2/ACK1 is a novel therapeutic target in triple negative breast cancerXinyan Wu, Muhammad Saddiq Zahari, Santosh Renuse, et al.
Nature Communications|September 27, 2023
Author Correction: Histone H2A Lys130 acetylation epigenetically regulates androgen production in prostate cancerThanh Nguyen, Dhivya Sridaran, Surbhi Chouhan, et al.
Anesthesiology|January 13, 2017
Retesting the Hypothesis of a Clinical Randomized Controlled Trial in a Simulation Environment to Validate Anesthesia Simulation in Error Research (the VASER Study)Alan F Merry, Jacqueline A Hannam, Craig S Webster, et al.
Nature Communications|June 9, 2023
Histone H2A Lys130 acetylation epigenetically regulates androgen production in prostate cancerThanh Nguyen, Dhivya Sridaran, Surbhi Chouhan, et al.
Oncogene|June 17, 2023
Epigenetic reprogramming of cell cycle genes by ACK1 promotes breast cancer resistance to CDK4/6 inhibitorMithila Sawant, Audrey Wilson, Dhivya Sridaran, et al.
Global Advances in Integrative Medicine and Health|May 25, 2026
Implementing an Integrative Medicine Group Visit Facilitator Training Program to Improve Chronic Pain Management in the Safety-NetEmiley Chang, Ruth Sie, Maria G Mechure, et al.
Cancers|January 11, 2024
Symptomatic Benign Prostatic Hyperplasia with Suppressed Epigenetic Regulator HOXB13 Shows a Lower Incidence of Prostate Cancer DevelopmentNimrod S Barashi, Tiandao Li, Duminduni H Angappulige, et al.
Oncogenesis|May 23, 2017
AKT is indispensable for coordinating Par-4/JNK cross talk in p21 downmodulation during ER stressR U Rasool, D Nayak, S Chakraborty, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 27, 2024
Prostate-Specific Membrane Antigen-Targeted Imaging and Its Correlation with HOXB13 ExpressionDuminduni Hewa Angappulige, Nimrod S Barashi, Nicholas Pickersgill, et al.
Pageof 32